RSA snaps up Allianz Commercial’s UK MD for chief executive role

RSA has announced that Nadia Cote will be joining the insurer as the chief executive of its Luxembourg arm.

Cote is moving to the firm from Allianz, where she most recently served as the UK commercial managing director.

She will succeed Lynn O’Leary at RSA, who is moving to a new role in Q1 2025.

In her new role, Cote will lead the RSA team in Luxembourg and have management responsibility for the firm’s UK specialty lines business.

The appointee brings over 25 years of commercial and specialty lines experience and, in addition to Allianz, has worked at AIG and Chubb.

Most of Cote’s career was spent at Chubb, with her serving in a range of roles such as head of major accounts and country manager.

She joined Allianz in May 2022 as regional managing director for London, before taking on her most recent role a year later.

Michael Miller, chief executive of global specialty lines at Intact, which owns RSA, said: “Cote is a well-known industry leader and we are pleased to have her lead our Europe and UK specialty lines groups.

“She brings established and long-standing relationships with key trading partners whereby we can create regional and global opportunities for customers and continued growth.

“She will lead our teams and continue to expand our solutions and capabilities, highlight our expertise in underwriting, risk control and claims, while outperforming on profitability in the UK and Europe.”

Succession

Meanwhile, O’Leary will return to the US to oversee Intact’s specialty lines business as president.

Louis Marcotte, Intact’s vice chair, will serve as interim chief executive of Luxembourg for a short period to assist with the leadership transition.

Miller said: “O’Leary led the transformation of our Europe business to be a focused specialty lines market.

“In that time, O’Leary and the team renewed key trading relationships and delivered new specialty verticals to brokers and customers, centred around the expertise of our local teams.

“I would like to thank O’Leary for her leadership and look forward to her continued contribution to our global specialty lines objectives in the US.”